A comparative study on the preference and suitability of oral pill therapy and drug-mixed nasal spray among allergic rhinitis patients in their 20s serving in the military.

A comparative study on the preference and suitability of oral pill therapy and H1-antihistamine and steroid combined intranasal spray among allergic rhinitis patients in their 20s serving in the military.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009130

Enrollment

140

Registered

2024-01-24

Start date

2023-03-10

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Group 1 takes 120 milligrams of Pecsone Tab. (Fexofenadine Hydrochloride 120mg, Chong kun Dang Pharmaceutical Corp.) once a day with pre-dinner water for oral treatment, and uses Cosue Tab. (Ps

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. All subjects of the study are patients in their 20s (19 to 29 years old) who are serving in the military and were diagnosed with allergic rhinitis 2. the study targets patients with visual analogue scores of less than 5 points according to the Allergic rhinitis and Its Impact on Asthma (ARIA) 2020 guidelines, and patients with visual pain scores of 5 or more who complain of intermittent symptoms among patients who are new to allergic rhinitis treatment.

Exclusion criteria

Exclusion criteria: 1. Patients with acute upper respiratory tract infections such as acute rhinitis and acute sinusitis other than allergic rhinitis 2. Discontinue the study and destroy data at any time when the patient does not want to participate in the study 3. If the patient has difficulty taking medication or using nasal spray for a variety of reasons 4. If the patient has difficulty in follow-up

Design outcomes

Primary

Measure	Time frame
Allergic Rhinitis Symptom Scale	—

Secondary

Measure	Time frame
Compliance;Side effect	—

Countries

Korea, Republic of

Contacts

Public ContactKyeong-Suk Park

1st Fighter Wing, aeromedicine battalion, Republic of Korea Air Force

play21713@daum.net+82-62-267-1713

Outcome results